arrow_back Back Filing freshness 20-F Q4 FY2025 SEC EDGAR

REGENTIS BIOMATERIALS LTD.

RGNT
$1.95 ▼ -0.05 (-2.50%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
4 Visible periods
5 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

REGENTIS BIOMATERIALS LTD. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth
Op. Margin
ROIC
FCF / Share
Trailing P/E
Price / Book 2.1x
FCF Yield
Debt / Equity 0.25
info Valuation on last close. End-of-day price, Aug 7, 2026.
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
0
Financial Health
41
Cash Quality
26

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 4 quarters